Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
KSX | re:super sopper takes out 1.6.... | 15:45 | 3 | 2.1K | |||
|
|||||||
KSX | symbol on asx now isn | 29/08/11 | 7 | 4.0K | |||
|
|||||||
KSX | Ann: Shareholder Update | 24/08/11 | 8 | 4.1K | |||
|
|||||||
KSX | shareholder update from new ce0 | 23/08/11 | 0 | 645 | |||
|
|||||||
KSX | super sopper takes out 1.6, next stop...... | 22/08/11 | 0 | 742 | |||
|
|||||||
KSX | Ann: Prestigious Analyst Group Consilium Commence | 19/08/11 | 10 | 4.3K | |||
|
|||||||
KSX | buyers now in control. | 18/08/11 | 10 | 3.9K | |||
|
|||||||
KSX | first impressions | 14/08/11 | 21 | 7.0K | |||
|
See All Discussions